Viral Clearance Market Analysis by Application (Blood, Recombinant Protein, Vaccines), by Method (Viral Inactivation, Viral Removal), by End User (Biopharmaceutical & Biotechnology Companies), and by Region - Forecast to 2029

Request Sample Page

The global viral clearance market size is estimated to be USD 590.2 million in 2021 and is expected to witness a CAGR of 13.81% during the forecast period. Rising R&D investment by biopharmaceutical and biotechnology companies for the development of novel drugs is a key driver for growth of the global market. Additionally, increase in prevalence of transmittable diseases, cross-infection cases during the COVID-19 pandemic, and growing demand for biologics for the treatment of chronic diseases are some of the other drivers propelling the market growth. However, high cost of drug development & manufacturing and lack of skilled personnel are expected to restrain the global market growth.

Global Viral Clearance Market Size (USD Million), 2021-2029

Source: Erevna Healthcare

By Application

Based on application, the market is segmented into blood & blood products, recombinant protein,  vaccines, and others. In 2021, the vaccines segment accounted for the significant share and is expected to grow with a lucrative CAGR during the forecast period. This can be attributed to the increasing application for disease prevention and need for novel vaccines worldwide. Recombinant proteins segment is projected to grow at a significant CAGR during the forecast period. This is attributed to rising demand for biologic drugs for the treatment of chronic diseases.

By Method

Based on method, the market is categorized into viral inactivation and viral removal. Viral inactivation segment is subdivided into low pH, pasteurization, and solvent detergent method; whereas viral removal is segmented into chromatography, nanofiltration, and precipitation. In 2021, the viral removal method accounted for a significant revenue share due to increasing prevalence of infectious diseases worldwide. However, the viral removal segment is anticipated to grow at a significant CAGR during the forecast period, due to the high funding in R&D by biopharmaceutical & biotechnology companies.

By End User

Based on end user, the market is categorized into biopharmaceutical & biotechnology companies, academic research organizations, Contract Research Organizations (CROs), and others. The biopharmaceutical & biotechnology companies segment accounted for the highest revenue in 2021 and is projected to maintain its dominance over the forecast period. Rising prevalence of infectious diseases, especially during the COVID-19 pandemic, is a key factor that drives the segment growth. The other end user segments include independent laboratories, cell banks, small culture laboratories, and medical device manufacturers.

Regional Insights

In 2021, North America accounted for the highest revenue share in the global market and is expected to maintain its dominance during the forecast period. This is attributed to the presence of leading biopharmaceutical companies, advanced healthcare infrastructure, and high investments in  R&D in this region. In the U.S., increasing mass production of monoclonal antibodies and government funding are fuelling the viral clearance market growth.

Asia Pacific market is expected to exhibit the fastest CAGR over the forecast period owing to the increasing incidence of viral diseases, demand for advanced medication and treatment, and focus of CROs & biopharmaceutical companies in this region. Countries such as India, Japan, and China hold promising growth opportunities due to rise in demand for generic medicines and increase in R&D investments in the countries.

Competitor Insights

Some of the key players in the viral clearance market are Merck KGaA (Germany); Charles River Laboratories, Inc., (U.S.); Lonza Group (Switzerland); Avance Biosciences, Inc. (U.S.); BSL BIOSERVICE Scientific Laboratories Munich GmbH (Germany); SGS S.A. (Switzerland); WuXi Biologics (China); Texcell SA (France); Asahi Kasei Medical Co., Ltd. (Japan) and Kedrion SPA (Italy). The leading players operating in the viral clearance industry are adopting various strategies including R&D investments, adaption of advanced techniques, mergers & acquisitions, and regional expansions to capture a maximum revenue share.

This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2021 to 2029. The viral clearance market report is categorized into the following segments and subsegments:

Viral Clearance Market, By Application (Revenue, USD Million, 2021 – 2029)

  • Blood & Blood Products
  • Recombinant Protein
  • Vaccines
  • Others

Viral Clearance Market, By Method (Revenue, USD Million, 2021 – 2029)

  • Viral Inactivation
  • Viral Removal

Viral Clearance Market, By End-User (Revenue, USD Million, 2021 – 2029)

  • Biopharmaceutical & Biotechnology Companies
  • Contract Research Organizations
  • Academic Research Organizations
  • Others

Viral Clearance Market, By Region (Revenue, USD Million, 2021 – 2029)

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Scope of Viral Clearance Market Report:

Key Parameters Details
Base Year
  • 2021
Forecast Period
  • 2022-2029
Study Coverage
  • Global and regional market size and revenue forecast
  • Segment market size and revenue forecast at global, regional, and country level
  • Competitive landscape (company share analysis, company profiles, recent development, competitive map analysis)
  • Conclusion and recommendations
Qualitative Analysis
  • Market drivers
  • Market restraints
  • Market opportunities
  • Recent market trends
  • Market challenges
  • Porter’s Five Forces analysis
  • PEST analysis
  • Value-chain analysis
  • COVID-19 impact analysis
Regional Market Scope
  • North America (U.S. and Canada)
  • Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
  • Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
  • Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
  • MEA (South Africa, GCC, Rest of MEA)
Company Profiles
  • Exhaustive profiles of top 10 players
  • 50+ other major players listing
15% Free Customization Available
  • You can customize the study scope to meet your exact requirement. Click here for more details

Table of Contents: Viral Clearance Market 2021-2029

  1. Research Methodology
    1. Study Objectives
    2. Study Scope
    3. Research Assumptions
    4. Research Framework
      1. Research Models
        1. Bottom-up Approach
        2. Top-down Approach
        3. Data Triangulation
      2. Data Procurement
        1. Internal Database
        2. Secondary Research
        3. Purchased Database
        4. Primary Research
      3. Data Analysis
        1. Data Validation
        2. Market Size Estimation
        3. Market Forecast Model
      4. Quality Assessment
  1. Introduction: Viral Clearance
  2. Executive Summary
    1. Global Market Scenario
    2. Segment Market Scenario
    3. Geographic Market Scenario
    4. COVID-19 Impact
    5. Competitive Landscape
  3. Market Dynamics
    1. Market Drivers
      1. Driver 1
      2. Driver 2
      3. Driver 3
      4. Driver 4
      5. Driver 5
    2. Market Restraint
      1. Restraint 1
      2. Restraint 2
      3. Restraint 3
      4. Restraint 4
    3. Market Opportunities
      1. Opportunity 1
      2. Opportunity 2
      3. Opportunity 3
      4. Opportunity 4
    4. Market Trends
      1. Trend 1
      2. Trend 2
      3. Trend 3
      4. Trend 4
    5. Market Challenges
      1. Challenge 1
      2. Challenge 2
      3. Challenge 3
      4. Challenge 4
  1. Market Environment Analysis
    1. Porter’s 5 Forces Analysis
    2. PESTEL Analysis
    3. Value Chain Analysis
    4. SWOT Analysis
    5. Benchmark
  2. COVID-19 Impact Analysis: Viral Clearance Market
    1. COVID-19: Overview
    2. COVID-19 Impact on the Global Market
    3. COVID-19 Impact on the Regional Markets
  3. Market Analysis by Method
    1. Viral removal
      1. Viral removal Market Forecast, 2021-2029 (USD Million)
    2. Viral inactivation
      1. Viral inactivation
  1. Market Analysis by Application
    1. Blood & blood products
      1. Blood & blood products Market Forecast, 2021-2029 (USD Million)
    2. Vaccines
      1. Vaccines Market Forecast, 2021-2029 (USD Million)
    3. Recombinant proteins
      1. Recombinant proteins Market Forecast, 2021-2029 (USD Million)
    4. Others
      1. Others Market Forecast, 2021-2029 (USD Million)
  1. Market Analysis by End-use
    1. Contract research organizations
      1. Contract research organizations Market Forecast, 2021-2029 (USD Million)
    2. Academic research institutes
      1. Academic research institutes Market Forecast, 2021-2029 (USD Million)
    3. Pharmaceutical & biotechnology companies
      1. Pharmaceutical & biotechnology companies Market Forecast, 2021-2029 (USD Million)
  1. Regional Market Analysis
    1. Regional Market Trends
    2. Regional Market: Comparative Analysis
  2. North America Viral Clearance Market
    1. North America Viral Clearance Market
      1. North America Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Method, 2021-2029 (USD Million)
        2. Market Size and Forecast by Application, 2021-2029 (USD Million)
        3. Market Size and Forecast by End-use, 2021-2029 (USD Million)
      2. S. Viral Clearance Market
        1. S. Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Method, 2021-2029 (USD Million)
          2. Market Size and Forecast by Application, 2021-2029 (USD Million)
          3. Market Size and Forecast by End-use, 2021-2029 (USD Million)
        2. Canada Viral Clearance Market
          1. Canada Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Method, 2021-2029 (USD Million)
            2. Market Size and Forecast by Application, 2021-2029 (USD Million)
            3. Market Size and Forecast by End-use, 2021-2029 (USD Million)
  1. Europe Viral Clearance Market
    1. Europe Viral Clearance Market
      1. Europe Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Method, 2021-2029 (USD Million)
        2. Market Size and Forecast by Application, 2021-2029 (USD Million)
        3. Market Size and Forecast by End-use, 2021-2029 (USD Million)
      2. Germany Viral Clearance Market
        1. Germany Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Method, 2021-2029 (USD Million)
          2. Market Size and Forecast by Application, 2021-2029 (USD Million)
          3. Market Size and Forecast by End-use, 2021-2029 (USD Million)
        2. UK Viral Clearance Market
          1. UK Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Method, 2021-2029 (USD Million)
            2. Market Size and Forecast by Application, 2021-2029 (USD Million)
            3. Market Size and Forecast by End-use, 2021-2029 (USD Million)
          2. France Viral Clearance Market
            1. France Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Method, 2021-2029 (USD Million)
              2. Market Size and Forecast by Application, 2021-2029 (USD Million)
              3. Market Size and Forecast by End-use, 2021-2029 (USD Million)
            2. Spain Viral Clearance Market
              1. Spain Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Method, 2021-2029 (USD Million)
                2. Market Size and Forecast by Application, 2021-2029 (USD Million)
                3. Market Size and Forecast by End-use, 2021-2029 (USD Million)
              2. Italy Viral Clearance Market
                1. Italy Market Size and Forecast, 2021-2029 (USD Million)
                  1. Market Size and Forecast by Method, 2021-2029 (USD Million)
                  2. Market Size and Forecast by Application, 2021-2029 (USD Million)
                  3. Market Size and Forecast by End-use, 2021-2029 (USD Million)
                2. Rest of Europe Viral Clearance Market
                  1. Rest of Europe Market Size and Forecast, 2021-2029 (USD Million)
                    1. Market Size and Forecast by Method, 2021-2029 (USD Million)
                    2. Market Size and Forecast by Application, 2021-2029 (USD Million)
                    3. Market Size and Forecast by End-use, 2021-2029 (USD Million)
  1. Asia Pacific Viral Clearance Market
    1. Asia Pacific Viral Clearance Market
      1. Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Method, 2021-2029 (USD Million)
        2. Market Size and Forecast by Application, 2021-2029 (USD Million)
        3. Market Size and Forecast by End-use, 2021-2029 (USD Million)
      2. Japan Viral Clearance Market
        1. Japan Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Method, 2021-2029 (USD Million)
          2. Market Size and Forecast by Application, 2021-2029 (USD Million)
          3. Market Size and Forecast by End-use, 2021-2029 (USD Million)
        2. China Viral Clearance Market
          1. China Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Method, 2021-2029 (USD Million)
            2. Market Size and Forecast by Application, 2021-2029 (USD Million)
            3. Market Size and Forecast by End-use, 2021-2029 (USD Million)
          2. India Viral Clearance Market
            1. India Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Method, 2021-2029 (USD Million)
              2. Market Size and Forecast by Application, 2021-2029 (USD Million)
              3. Market Size and Forecast by End-use, 2021-2029 (USD Million)
            2. South Korea Viral Clearance Market
              1. South Korea Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Method, 2021-2029 (USD Million)
                2. Market Size and Forecast by Application, 2021-2029 (USD Million)
                3. Market Size and Forecast by End-use, 2021-2029 (USD Million)
              2. Australia Viral Clearance Market
                1. Australia Market Size and Forecast, 2021-2029 (USD Million)
                  1. Market Size and Forecast by Method, 2021-2029 (USD Million)
                  2. Market Size and Forecast by Application, 2021-2029 (USD Million)
                  3. Market Size and Forecast by End-use, 2021-2029 (USD Million)
                2. Rest of Asia Pacific Viral Clearance Market
                  1. Rest of Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
                    1. Market Size and Forecast by Method, 2021-2029 (USD Million)
                    2. Market Size and Forecast by Application, 2021-2029 (USD Million)
                    3. Market Size and Forecast by End-use, 2021-2029 (USD Million)
  1. Latin America Viral Clearance Market
    1. Latin America Viral Clearance Market
      1. Latin America Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Method, 2021-2029 (USD Million)
        2. Market Size and Forecast by Application, 2021-2029 (USD Million)
        3. Market Size and Forecast by End-use, 2021-2029 (USD Million)
      2. Brazil Viral Clearance Market
        1. Brazil Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Method, 2021-2029 (USD Million)
          2. Market Size and Forecast by Application, 2021-2029 (USD Million)
          3. Market Size and Forecast by End-use, 2021-2029 (USD Million)
        2. Mexico Viral Clearance Market
          1. Mexico Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Method, 2021-2029 (USD Million)
            2. Market Size and Forecast by Application, 2021-2029 (USD Million)
            3. Market Size and Forecast by End-use, 2021-2029 (USD Million)
          2. Argentina Viral Clearance Market
            1. Argentina Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Method, 2021-2029 (USD Million)
              2. Market Size and Forecast by Application, 2021-2029 (USD Million)
              3. Market Size and Forecast by End-use, 2021-2029 (USD Million)
            2. Rest of Latin America Viral Clearance Market
              1. Rest of Latin America Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Method, 2021-2029 (USD Million)
                2. Market Size and Forecast by Application, 2021-2029 (USD Million)
                3. Market Size and Forecast by End-use, 2021-2029 (USD Million)
  1. MEA Viral Clearance Market
    1. MEA Viral Clearance Market
      1. MEA Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Method, 2021-2029 (USD Million)
        2. Market Size and Forecast by Application, 2021-2029 (USD Million)
        3. Market Size and Forecast by End-use, 2021-2029 (USD Million)
      2. GCC Viral Clearance Market
        1. GCC Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Method, 2021-2029 (USD Million)
          2. Market Size and Forecast by Application, 2021-2029 (USD Million)
          3. Market Size and Forecast by End-use, 2021-2029 (USD Million)
        2. South Africa Viral Clearance Market
          1. South Africa Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Method, 2021-2029 (USD Million)
            2. Market Size and Forecast by Application, 2021-2029 (USD Million)
            3. Market Size and Forecast by End-use, 2021-2029 (USD Million)
          2. Rest of MEA Viral Clearance Market
            1. Rest of MEA Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Method, 2021-2029 (USD Million)
              2. Market Size and Forecast by Application, 2021-2029 (USD Million)
              3. Market Size and Forecast by End-use, 2021-2029 (USD Million)
  1. Competitor Analysis
    1. Market Share Analysis, 2021 & 2029
    2. Competitive Mapping
    3. Key Players Market Place Analysis
    4. Major Recent Developments
  2. Company Profiles
    1. Wuxi Biologics (Cayman) (China)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    2. Merck KGaA (Germany)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    3. Charles River Laboratories International Inc. (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    4. Texcell Inc. (France)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    5. Kedrion (Italy)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    6. Vironova Biosafety (Sweden)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    7. Clean Cells (France)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    8. BSL BIOSERVICE Scientific Laboratories Munich GmbH (Germany)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    9. ViruSure GmbH (Austria)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    10. GlaxoSmithKline Plc (U.K.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    11. Company 11
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    12. Company 12
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    13. Company 13
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    14. Company 14
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    15. Company 15
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    16. Others Prominent Players

Conclusion & Recommendations

Select License Type

Buy Now

7 Reasons to Choose EHMR Reports

  • Customer’s Satisfaction

    First and foremost client’s satisfaction, which is very important for Erevna Healthcare and we are committed towards it

  • Client Report

    Customised reports

    Expert in healthcare domain and in depth insights on the report. Erevna Healthcare also customise reports as per the client’s requirement

  • Analyst Support

    Experienced team of analysts with strong background in Pharma, Life Sciences and Biotechnology

  • Assured Quality

    Each report passes through three tiers of quality check

  • Stick to the timeline

    Stick to the timeline

    Erevna Healthcare analysts stick to the timeline

  • Quick delivery

    Quick delivery of reports as per client’s request in three different forms i.e. pdf, ppt and word

  • 24x7 Supprt

    24*7 Support

    24*7 Support post delivery/dispatch of all the reports

Trending Reports